ATE305297T1 - Verwendung von histonedeacetylasehemmern zur behandlung von papillomaviren assoziierte krankheiten - Google Patents

Verwendung von histonedeacetylasehemmern zur behandlung von papillomaviren assoziierte krankheiten

Info

Publication number
ATE305297T1
ATE305297T1 AT01108923T AT01108923T ATE305297T1 AT E305297 T1 ATE305297 T1 AT E305297T1 AT 01108923 T AT01108923 T AT 01108923T AT 01108923 T AT01108923 T AT 01108923T AT E305297 T1 ATE305297 T1 AT E305297T1
Authority
AT
Austria
Prior art keywords
inhibitor
treatment
hpv16
hdac
histone deacetylase
Prior art date
Application number
AT01108923T
Other languages
English (en)
Inventor
Patrick Finzer
Hausen Harald Zur
Frank Roesl
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE305297T1 publication Critical patent/ATE305297T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01108923T 2001-04-10 2001-04-10 Verwendung von histonedeacetylasehemmern zur behandlung von papillomaviren assoziierte krankheiten ATE305297T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01108923A EP1249246B1 (de) 2001-04-10 2001-04-10 Verwendung von Histonedeacetylasehemmern zur Behandlung von Papillomaviren assoziierte Krankheiten

Publications (1)

Publication Number Publication Date
ATE305297T1 true ATE305297T1 (de) 2005-10-15

Family

ID=8177103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01108923T ATE305297T1 (de) 2001-04-10 2001-04-10 Verwendung von histonedeacetylasehemmern zur behandlung von papillomaviren assoziierte krankheiten

Country Status (5)

Country Link
US (1) US20040132817A1 (de)
EP (1) EP1249246B1 (de)
AT (1) ATE305297T1 (de)
DE (1) DE60113645T2 (de)
WO (1) WO2002083173A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (de) 2001-09-10 2003-03-12 Lunamed AG Darreichungsformen mit verlängerter Wirkstofffreisetzung
CA2495354A1 (en) * 2002-08-20 2004-03-04 Yamanouchi Pharmaceutical Co., Ltd. An agent for inhibiting articular cartilage extracellular matrix degradation
US20050222013A1 (en) * 2003-01-16 2005-10-06 Georgetown University Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
US20050059682A1 (en) * 2003-09-12 2005-03-17 Supergen, Inc., A Delaware Corporation Compositions and methods for treatment of cancer
JP2009501236A (ja) 2005-07-14 2009-01-15 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2574531C (en) * 2007-01-19 2016-10-25 The University Of British Columbia Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
JP5468015B2 (ja) 2008-01-08 2014-04-09 アクセリア ファーマシューティカルズ 抗菌ペプチド系に対する作動薬
US20120269818A1 (en) * 2011-04-25 2012-10-25 Ozbun Michelle A Methods for treating infection by hpv
WO2014138507A1 (en) * 2013-03-06 2014-09-12 C & C Biopharma, Llc Treatment of cervical cancer and/or ovarian cancer using a transcription factor modulator
WO2015031759A1 (en) * 2013-08-31 2015-03-05 The Wistar Institute Of Anatomy And Biology Methods and compositions for re-activating epstein-barr virus and screening compounds therefor
WO2021217014A1 (en) * 2020-04-23 2021-10-28 Georgetown University Combination therapy of artemisinin-related compounds and histone deacetylase inhibitors for treatment of hpv-related benign, premalignant, and malignant diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61176523A (ja) * 1985-01-30 1986-08-08 Teruhiko Beppu 制癌剤
EP0827742A1 (de) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Verwendung von Histondeacetylasehemmern zur Behandlung von Fibrose oder Zirrhose
US6124495A (en) * 1997-03-11 2000-09-26 Beacon Laboratories, Inc. Unsaturated oxyalkylene esters and uses thereof

Also Published As

Publication number Publication date
DE60113645D1 (de) 2006-02-09
US20040132817A1 (en) 2004-07-08
EP1249246A1 (de) 2002-10-16
WO2002083173A1 (en) 2002-10-24
EP1249246B1 (de) 2005-09-28
DE60113645T2 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
Tomaić Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites
DE60113645D1 (de) Verwendung von Histonedeacetylasehemmern zur Behandlung von Papillomaviren assoziierte Krankheiten
Bodily et al. Human papillomavirus E7 enhances hypoxia-inducible factor 1–mediated transcription by inhibiting binding of histone deacetylases
Altamura et al. Transforming properties of Felis catus papillomavirus type 2 E6 and E7 putative oncogenes in vitro and their transcriptional activity in feline squamous cell carcinoma in vivo
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
DE69925268D1 (de) Dipeptid kaspase inhibitoren und deren verwendung
O'Connell et al. Interferon‐γ sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis
EA200601239A1 (ru) Замещённые хинолиновые соединения
Minashima et al. Lithium protects against cartilage degradation in osteoarthritis
EA199900769A1 (ru) N-гидрокси-2-(алкил-, арил- или гетероарилсульфанил, -сульфинил или -сульфонил)-3-замещенные алкилов, арилов или гетероариламидов в качестве ингибиторов матриксных металлопротеиназ
EA199900669A1 (ru) Промежуточные соединения для получения замещенных n-[аминоиминометил или аминометил)фенил]пропиламидов
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
Mallari et al. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB
ATE399012T1 (de) Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren
NO972538D0 (no) Nye sulfonamider
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0409109A (pt) novos compostos
NO20084857L (no) HPV-16-basert papillomavirus vaksine
CY1109328T1 (el) Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου
BR0316606A (pt) Derivados de aminoindazóis e sua utilização como inibidores de quinases
JOP20220152A1 (ar) مشتقات 3-(5- ميثوكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخداماتها
CN106138018B (zh) 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用
Lin et al. Diallyl disulfide (DADS) induces apoptosis in human cervical cancer Ca Ski cells via reactive oxygen species and Ca2+-dependent mitochondria-dependent pathway
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
BRPI0411085A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties